Immunic Therapeutics logo

Director, Safety Systems & Analytics

Immunic Therapeutics

Any City, USRemotePosted 2 days ago$220,000 - $260,000/year
Full TimeDirector & AbovePharmacovigilance / Drug SafetyBiotechnology
Original posting ↗

Summary

We are seeking a Director, Safety Systems & Analytics to serve as a strategic and operational leader overseeing the optimization, compliance, and continuous evolution of Immunic's Global Pharmacovigilance and Patient Safety systems, technology, data, and analytics capabilities, reporting to the VP of Global Patient Safety. You will provide subject matter expertise across the safety systems landscape, including the Global Safety Database, signal detection platforms, safety reporting and analytics tools, and case processing technologies - partnering closely with Clinical Development, Regulatory Affairs, Quality, IT, and external vendors to ensure systems are compliant, validated, scalable, and inspection-ready, while leading efforts to improve data quality, automation, and analytics, and overseeing vendors, system implementations/upgrades, validation, UAT, and change management.

Job description

Summary

We are seeking a Director, Safety Systems & Analytics to serve as a strategic and operational leader overseeing the optimization, compliance, and continuous evolution of Immunic's Global Pharmacovigilance and Patient Safety systems, technology, data, and analytics capabilities, reporting to the VP of Global Patient Safety. You will provide subject matter expertise across the safety systems landscape, including the Global Safety Database, signal detection platforms, safety reporting and analytics tools, and case processing technologies - partnering closely with Clinical Development, Regulatory Affairs, Quality, IT, and external vendors to ensure systems are compliant, validated, scalable, and inspection-ready, while leading efforts to improve data quality, automation, and analytics, and overseeing vendors, system implementations/upgrades, validation, UAT, and change management.

You must bring a collaborative leadership style that combines strong pharmacovigilance knowledge with systems expertise, business analysis, and data and analytics capabilities, translating business needs into sustainable technology solutions.

Responsibilities

  • Develop and maintain the strategic vision, roadmap, and governance for Immunic's PV/Patient Safety systems, analytics, data, and technology ecosystem, serving as the primary PV Systems SME and strategic advisor to PV leadership, while identifying opportunities for automation, AI, and process optimization.
  • Provide strategic and operational oversight of the Global Safety Database and associated PV applications, ensuring systems remain compliant, validated, secure, and reliable, including configuration, upgrades, interfaces, access management, and integration with clinical, regulatory, quality, and other enterprise platforms.
  • Partner with PV and cross-functional stakeholders to translate business needs into requirements (URS, functional/technical specs), serving as process and systems SME for case processing, regulatory reporting, signal management, and safety data review, while maintaining associated documentation.
  • Lead the strategic use of PV data and analytics — including dashboards, KPIs, and management reports — to support safety surveillance, compliance monitoring, and decision-making, ensuring data outputs are accurate, reproducible, and fit for purpose across regulatory submissions and safety reviews.
  • Lead or oversee implementation of new PV systems, upgrades, integrations, and migrations, partnering with IT, QA, and vendors on system lifecycle management, validation, UAT, and change control to ensure changes don't adversely affect compliance, patient safety, or data integrity.
  • Ensure PV systems and processes comply with applicable global regulations (21 CFR Part 11, GCP/ICH, EU Annex 11) and maintain continuous inspection readiness, serving as PV Systems SME during regulatory inspections and audits and supporting remediation activities.
  • Ensure appropriate controls for data exchange under SDEAs, PVAs, and other external partnership agreements.
  • Provide strategic oversight of PV systems and technology vendors, including service levels, KPIs, vendor selection/RFPs, and performance management, partnering with Procurement, Quality, and IT on vendor strategy, contracts, and budgets.
  • Lead PV systems training, onboarding, and knowledge management, ensuring training materials and documentation remain current and promoting consistent adoption of PV technologies across the organization.
  • Lead PV systems projects from concept through implementation, managing scope, timelines, risks, and budgets, and partnering with IT to align PV technology investments with broader enterprise strategy.

Qualifications & Experience

  • Bachelor's degree in Life Sciences, Computer Science, Information Technology, Pharmacy, Nursing, or a related discipline (advanced degree preferred), with 10–15 years of progressive experience in Pharmacovigilance, Drug Safety, Safety Systems, Clinical Development, or related pharmaceutical/biotechnology functions.
  • Significant experience with implementation, administration, validation, and lifecycle management of PV or Drug Safety systems, including strong experience with Global Safety Databases (e.g., Oracle Argus, Veeva Safety) and demonstrated experience with integrations, data migration, upgrades, and interfaces.
  • Strong understanding of pharmacovigilance processes — case intake/processing, regulatory reporting, signal management, aggregate reporting, compliance monitoring, and safety data review — along with knowledge of 21 CFR Part 11, ICH/GCP, EU Annex 11, and applicable global PV regulations.
  • Experience with safety analytics, reporting platforms, dashboards, KPIs, and data visualization tools, along with an understanding of relational databases, data structures, and business intelligence concepts; experience with SQL, SAS, or comparable technologies is advantageous.
  • Experience leading UAT, computerized system validation, change control, CAPA, and deviation management, as well as vendor oversight of external PV technology/service providers and support of regulatory inspections, partner audits, and inspection readiness.
  • Experience with signal detection/management systems and AI, automation, or other emerging technology applications in Pharmacovigilance is preferred, along with experience supporting technology strategy in a growing biotech/pharma organization transitioning from clinical development to commercialization.

Requirements

  • Bachelor's degree in Life Sciences, Computer Science, Information Technology, Pharmacy, Nursing, or a related discipline
  • 10–15 years of progressive experience in Pharmacovigilance, Drug Safety, Safety Systems, Clinical Development, or related pharmaceutical/biotechnology functions
  • Significant experience with implementation, administration, validation, and lifecycle management of PV or Drug Safety systems
  • Strong experience with Global Safety Databases (e.g., Oracle Argus, Veeva Safety)
  • Demonstrated experience with integrations, data migration, upgrades, and interfaces
  • Strong understanding of pharmacovigilance processes including case intake/processing, regulatory reporting, signal management, aggregate reporting, compliance monitoring, and safety data review
  • Knowledge of 21 CFR Part 11, ICH/GCP, EU Annex 11, and applicable global PV regulations
  • Experience with safety analytics, reporting platforms, dashboards, KPIs, and data visualization tools
  • Understanding of relational databases, data structures, and business intelligence concepts
  • Experience leading UAT, computerized system validation, change control, CAPA, and deviation management
  • Vendor oversight of external PV technology/service providers
  • Support of regulatory inspections, partner audits, and inspection readiness

Benefits

  • Equity
  • Bonus

Company overview

Immunic Therapeutics (Nasdaq: IMUX) is a late-stage biotechnology company pioneering the development of novel oral therapies for chronic inflammatory and autoimmune diseases, with a primary focus on neurologic conditions such as multiple sclerosis (MS). Headquartered in New York City with additional operations in Gräfelfing, Germany, the company is dedicated to advancing a clinical pipeline of orally administered, small molecule therapeutics. Its lead program, vidofludimus calcium (IMU-838), is a first-in-class oral therapy that combines neuroprotective effects through nuclear receptor-related 1 (Nurr1) activation with anti-inflammatory and anti-viral properties via selective dihydroorotate dehydrogenase (DHODH) inhibition. Vidofludimus calcium is currently in Phase 3 clinical trials (ENSURE program) for relapsing multiple sclerosis, with top-line data expected by the end of 2026, and has demonstrated promising therapeutic activity in Phase 2 trials for both relapsing-remitting and progressive MS. The company's pipeline also includes earlier-stage programs, such as IMU-856 targeting gastrointestinal diseases and IMU-381 for gastrointestinal applications. Founded in 2016, Immunic employs approximately 51-200 people and is transitioning toward becoming a fully integrated commercial-stage biotechnology company.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.